Literature DB >> 19768504

Impact of neonatal antibiotic treatment on the biodiversity of the murine intestinal Lactobacillus community.

Jing Yuan1, Hong Wei, Benhua Zeng, Huan Tang, Wenxia Li, Zhixue Zhang.   

Abstract

In this study, we investigated the impact of neonatal amoxicillin treatment on the development of the murine intestinal Lactobacillus community. Suckling BALB/c mice received a daily intragastric gavage of amoxicillin or saline from postnatal day 7 (PND 7) to PND 20. Just after the treatment (PND 21) and 5 weeks later (PND 56), the colon digesta samples were analyzed by Lactobacillus-specific quantitative real-time PCR analysis and PCR-denaturing gradient gel electrophoresis (DGGE) technique. Real-time PCR results showed that the levels of lactobacilli in the treatment group were similar to those in the control at PND 56. However, in DGGE analysis the number of DGGE bands and Shannon index were decreased significantly in comparison with control (P < 0.05). The dominant Lactobacillus strain in the murine colon changed from L. johnsonii to L. murinus. These results demonstrated that neonatal amoxicillin treatment led to a significant impact on the biodiversity of the murine intestinal Lactobacillus community within a long-time period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19768504     DOI: 10.1007/s00284-009-9492-x

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  29 in total

1.  Trends in prescribing antibiotics for children in Dutch general practice.

Authors:  Hanneke B M Otters; Johannes C van der Wouden; Francois G Schellevis; Lisette W A van Suijlekom-Smit; Bart W Koes
Journal:  J Antimicrob Chemother       Date:  2004-01-16       Impact factor: 5.790

2.  Parenteral long-acting amoxicillin reduces intestinal bacterial community diversity in piglets even 5 weeks after the administration.

Authors:  Pawel Janczyk; Robert Pieper; Wolfgang Bernhard Souffrant; Diane Bimczok; Hermann-Josef Rothkötter; Hauke Smidt
Journal:  ISME J       Date:  2007-06       Impact factor: 10.302

3.  Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome.

Authors:  Alexandra Schumann; Sophie Nutten; Dominique Donnicola; Elena M Comelli; Robert Mansourian; Christine Cherbut; Irène Corthesy-Theulaz; Clara Garcia-Rodenas
Journal:  Physiol Genomics       Date:  2005-08-30       Impact factor: 3.107

4.  Factors influencing the composition of the intestinal microbiota in early infancy.

Authors:  John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

5.  The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics.

Authors:  R Bennet; M Eriksson; C E Nord
Journal:  Infection       Date:  2002-06       Impact factor: 3.553

6.  Dietary supplementation with sorbitol results in selective enrichment of lactobacilli in rat intestine.

Authors:  Luz Adriana Sarmiento-Rubiano; Manuel Zúñiga; Gaspar Pérez-Martínez; María Jesús Yebra
Journal:  Res Microbiol       Date:  2007-08-02       Impact factor: 3.992

7.  Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR.

Authors:  Jean-Marc Delroisse; Anne-Lise Boulvin; Isabelle Parmentier; Robin Dubois Dauphin; Micheline Vandenbol; Daniel Portetelle
Journal:  Microbiol Res       Date:  2008       Impact factor: 5.415

8.  Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children.

Authors:  Sylvia Cruchet; Maria Clara Obregon; Gabriela Salazar; Eric Diaz; Martin Gotteland
Journal:  Nutrition       Date:  2003-09       Impact factor: 4.008

9.  Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins.

Authors:  Dominique Granato; Gabriela E Bergonzelli; Raymond David Pridmore; Laure Marvin; Martine Rouvet; Irène E Corthésy-Theulaz
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

View more
  6 in total

1.  Qualitative and Semiquantitative Analysis of Fecal Bifidobacterium Species in Centenarians Living in Bama, Guangxi, China.

Authors:  Fang Wang; Guohong Huang; Da Cai; Danlei Li; Xiaolin Liang; Ting Yu; Peihong Shen; Haiyan Su; Jidong Liu; Hongcang Gu; Mouming Zhao; Quanyang Li
Journal:  Curr Microbiol       Date:  2015-03-25       Impact factor: 2.188

Review 2.  An Overview of Antibiotic Resistance and Abiotic Stresses Affecting Antimicrobial Resistance in Agricultural Soils.

Authors:  Abdullah Kaviani Rad; Angelika Astaykina; Rostislav Streletskii; Yeganeh Afsharyzad; Hassan Etesami; Mehdi Zarei; Siva K Balasundram
Journal:  Int J Environ Res Public Health       Date:  2022-04-12       Impact factor: 4.614

3.  Intestinal Lactobacillus community structure and its correlation with diet of Southern Chinese elderly subjects.

Authors:  Yuanyuan Pan; Fang Wang; Da-Wen Sun; Quanyang Li
Journal:  J Microbiol       Date:  2016-08-31       Impact factor: 3.422

4.  Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis.

Authors:  Xiaofei Liu; Qinghua Zou; Benhua Zeng; Yongfei Fang; Hong Wei
Journal:  Curr Microbiol       Date:  2013-03-13       Impact factor: 2.188

5.  In vitro culture conditions for maintaining a complex population of human gastrointestinal tract microbiota.

Authors:  Bong-Soo Kim; Jong Nam Kim; Carl E Cerniglia
Journal:  J Biomed Biotechnol       Date:  2011-07-24

6.  The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice.

Authors:  Esi S Lamousé-Smith; Alice Tzeng; Michael N Starnbach
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.